Published in J Antimicrob Chemother on March 01, 1993
Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev (2010) 2.32
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob Agents Chemother (1995) 1.65
Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist (2011) 1.21
Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle. J Physiol (1999) 0.82
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects. Antimicrob Agents Chemother (2013) 0.81
Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders. Neuropsychiatry (London) (2012) 0.79
Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis. PLoS One (2015) 0.77
Macrolides and associated antibiotics based on similar mechanism of action like lincosamides in malaria. Malar J (2016) 0.76
Risk of cardiovascular effects with azithromycin. J Clin Diagn Res (2015) 0.75
Macrolide resistance in Streptococcus species. J Pharm Bioallied Sci (2015) 0.75
Spectrophotometric Investigations of Macrolide Antibiotics: A Brief Review. Anal Chem Insights (2015) 0.75
Evaluation of Possible Genotoxic Activity of Dirithromycin in Cultured Human Lymphocytes. J Toxicol (2015) 0.75
Retracted Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus. AAPS PharmSciTech (2013) 0.75
The Effect of Cationic Polyamidoamine Dendrimers on Physicochemical Characteristics of Hydrogels with Erythromycin. Int J Mol Sci (2015) 0.75
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients. Sci Rep (2016) 0.75
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Antimicrob Agents Chemother (1988) 2.52
Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J (1999) 2.33
Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets (2006) 1.96
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338. Antimicrob Agents Chemother (1989) 1.94
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Commun (1993) 1.91
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol (1995) 1.88
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. J Med Chem (2000) 1.87
Comparative in vitro activity of a new quinolone, AM-1091. Antimicrob Agents Chemother (1989) 1.78
In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105. Antimicrob Agents Chemother (1988) 1.75
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. J Antimicrob Chemother (1998) 1.62
The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci (1986) 1.61
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrob Agents Chemother (1988) 1.56
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1988) 1.53
Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet (1992) 1.50
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent. Eur J Clin Microbiol Infect Dis (1988) 1.43
Classification of oral cephalosporins. A matter for debate. Int J Antimicrob Agents (2001) 1.38
Detection of an atypical 7q11.23 deletion in Williams syndrome patients which does not include the STX1A and FZD3 genes. J Med Genet (1999) 1.35
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. Eur J Clin Microbiol Infect Dis (1989) 1.28
Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. J Biol Chem (1991) 1.28
Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur J Hum Genet (1999) 1.24
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother (2000) 1.23
Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli. Amino Acids (2006) 1.21
Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Structure (2000) 1.16
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients. Ann Oncol (2001) 1.12
Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification. J Med Genet (2007) 1.10
Adverse effects of macrolide antibacterials. Drug Saf (1993) 1.09
Chromosomal microarray as first-tier approach in low-risk pregnancies: detection rate should not be the only criterion for its application. Ultrasound Obstet Gynecol (2014) 1.07
Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. Drugs (1983) 1.06
The clinical utility and indications of chromosomal microarray analysis in prenatal diagnosis. BJOG (2013) 1.06
Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. J Exp Med (1987) 1.05
Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res (1997) 1.05
Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. J Neurochem (2001) 1.04
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant (2004) 1.01
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I). Clin Pharmacokinet (1989) 0.98
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study. Br J Cancer (2002) 0.94
Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity. Amino Acids (2002) 0.93
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II). Clin Pharmacokinet (1989) 0.93
Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. Antimicrob Agents Chemother (1993) 0.92
The reaction of Criegee intermediates with NO, RO2, and SO2, and their fate in the atmosphere. Phys Chem Chem Phys (2012) 0.91
Bacillus subtilis spores as a natural pro-host oral agent. Preliminary data in children. Chemioterapia (1984) 0.90
Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. An hypothesis for cell death in aging and disease. Ann N Y Acad Sci (1989) 0.90
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection. Bone Marrow Transplant (2007) 0.90
Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. Eur J Clin Microbiol Infect Dis (1999) 0.90
Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity. FEBS Lett (1993) 0.89
Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res (1999) 0.88
Ideal microbiological and pharmacological characteristics of a quality antimicrobial agent: comparing original and generic molecules. J Chemother (2007) 0.88
Excitatory amino acid receptors coupled with guanylate cyclase in primary cultures of cerebellar granule cells. J Neurosci (1987) 0.88
Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cells. Cancer Res (1985) 0.88
Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. Cancer Res (1988) 0.88
Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection. Chemotherapy (1998) 0.87
Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System. Chemioterapia (1985) 0.87
Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay. Anticancer Drugs (1995) 0.87
Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin. Cancer Treat Rep (1987) 0.87
Another patient with 12q13 microduplication. Am J Med Genet A (2013) 0.86
Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis. Calcif Tissue Int (1982) 0.86
Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups. Long-term results of a randomised multicentre study. Eur J Cancer (1993) 0.86
Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas. Scand J Gastroenterol (2000) 0.86
Pharmacokinetics of azithromycin in patients with impaired hepatic function. J Antimicrob Chemother (1993) 0.86
HDR (Hypoparathyroidism, Deafness, Renal dysplasia) syndrome associated to GATA3 gene duplication. Clin Genet (2009) 0.85
Infections in immunocompromised patients. II. Established therapy and its limitations. Clin Ther (1985) 0.85
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates. Chemioterapia (1987) 0.85
Mutations of the APC gene in human sporadic colorectal cancers. Scand J Gastroenterol (2002) 0.85
Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm). J Inorg Biochem (1997) 0.84
Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines. Cancer Res (1985) 0.84
Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. J Antimicrob Chemother (1990) 0.83
Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. Cancer Lett (2000) 0.83
[The use of fluorescence microscopy for histopathologic preparations stained by hematoxylin eosin]. Pathologica (1971) 0.82
New insight into the clinical pharmacokinetics of cefaclor: tissue penetration. J Chemother (2000) 0.82
Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial. Eur Urol (1987) 0.82
Long-term azithromycin in cystic fibrosis: another possible mechanism of action? J Chemother (2005) 0.81
Tissue distribution of cefotetan in patients with Crohn's disease. Chemotherapy (1991) 0.81
Presence of 'RNA immuno-carrier' in immune rabbits' serum. Experientia (1964) 0.81
Familial X;Y translocation with distinct phenotypic consequences: Characterization using FISH and array CGH. Am J Med Genet A (2010) 0.81
Intracellular enhancement of intact antisense oligonucleotide steady-state levels by cationic lipids. Anticancer Drug Des (1994) 0.81
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. J Chemother (2001) 0.81
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study. Dig Liver Dis (2004) 0.81
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin. Anticancer Drug Des (1998) 0.81
Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells. Clin Cancer Res (1998) 0.80
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? Drugs (1997) 0.80
Teicoplanin--its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Italian Study Groups for Antimicrobial Prophylaxis in Orthopaedic Surgery and Burns. Eur J Surg Suppl (1992) 0.80
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor. Int J Cancer (2000) 0.80
Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. Antimicrob Agents Chemother (1994) 0.80
Antihistamine terfenadine potentiates NMDA receptor-mediated calcium influx, oxygen radical formation, and neuronal death. Brain Res (2000) 0.80
DL-threo-3-hydroxyaspartate reduces NMDA receptor activation by glutamate in cultured neurons. Eur J Pharmacol (1991) 0.80